This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hopcroft, K. Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis’. Br. J. Cancer https://doi.org/10.1038/s41416-018-0205-8 (2018).
Curtis, H. J., Walker, A. J. & Goldacre, B. Impact of NICE Guidance on tamoxifen prescribing in England 2011–2017 - an interrupted time series analysis. BMJ Open 118, 1268–1275 (2018).
Smith, S. G., Foy, R., McGowan, J. A., Kobayashi, L. C., de Censi, A. & Brown, K. et al. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes. Br. J. Gen. Pract. 67, e414–e427 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.G. has received funding from the Health Foundation, the National Institute for Health Research School of Primary Care Research, the NIHR Biomedical Research Centre Oxford, the West of England Academic Health Sciences Network and NHS England for work on UK prescribing the data. H.C. is employed on these grants. B.G. has additionally received funding from the Laura and John Arnold Foundation, the Wellcome Trust, and the World Health Organisation to work on better use of the data in medicine; and receives personal income from speaking and writing for lay audiences on the misuse of science.
Note
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.
Additional information
Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.)
Rights and permissions
About this article
Cite this article
Curtis, H., Goldacre, B. Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”. Br J Cancer 119, 658 (2018). https://doi.org/10.1038/s41416-018-0226-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-018-0226-3